Towards Understanding the Mechanism of Contrastive Learning via Similarity Structure: A Theoretical Analysis

Contrastive learning is an efficient approach to self-supervised representation learning. Although recent studies have made progress in the theoretical understanding of contrastive learning, the investigation of how to characterize the clusters of the learned representations is still limited. In this paper, we aim to elucidate the characterization from theoretical perspectives. To this end, we consider a kernel-based contrastive learning framework termed Kernel Contrastive Learning (KCL), where kernel functions play an important role when applying our theoretical results to other frameworks. We introduce a formulation of the similarity structure of learned representations by utilizing a statistical dependency viewpoint. We investigate the theoretical properties of the kernel-based contrastive loss via this formulation. We first prove that the formulation characterizes the structure of representations learned with the kernel-based contrastive learning framework. We show a new upper bound of the classification error of a downstream task, which explains that our theory is consistent with the empirical success of contrastive learning. We also establish a generalization error bound of KCL. Finally, we show a guarantee for the generalization ability of KCL to the downstream classification task via a surrogate bound

Learning Domain Invariant Representations by Joint Wasserstein Distance Minimization

Domain shifts in the training data are common in practical applications of machine learning, they occur for instance when the data is coming from different sources. Ideally, a ML model should work well independently of these shifts, for example, by learning a domain-invariant representation. Moreover, privacy concerns regarding the source also require a domain-invariant representation. In this work, we provide theoretical results that link domain invariant representations -- measured by the Wasserstein distance on the joint distributions -- to a practical semi-supervised learning objective based on a cross-entropy classifier and a novel domain critic. Quantitative experiments demonstrate that the proposed approach is indeed able to practically learn such an invariant representation (between two domains), and the latter also supports models with higher predictive accuracy on both domains, comparing favorably to existing techniques.Comment: 20 pages including appendix. Under Revie

Denoising Cosine Similarity: A Theory-Driven Approach for Efficient Representation Learning

Representation learning has been increasing its impact on the research and practice of machine learning, since it enables to learn representations that can apply to various downstream tasks efficiently. However, recent works pay little attention to the fact that real-world datasets used during the stage of representation learning are commonly contaminated by noise, which can degrade the quality of learned representations. This paper tackles the problem to learn robust representations against noise in a raw dataset. To this end, inspired by recent works on denoising and the success of the cosine-similarity-based objective functions in representation learning, we propose the denoising Cosine-Similarity (dCS) loss. The dCS loss is a modified cosine-similarity loss and incorporates a denoising property, which is supported by both our theoretical and empirical findings. To make the dCS loss implementable, we also construct the estimators of the dCS loss with statistical guarantees. Finally, we empirically show the efficiency of the dCS loss over the baseline objective functions in vision and speech domains

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Spectral Embedded Deep Clustering

We propose a new clustering method based on a deep neural network. Given an unlabeled dataset and the number of clusters, our method directly groups the dataset into the given number of clusters in the original space. We use a conditional discrete probability distribution defined by a deep neural network as a statistical model. Our strategy is first to estimate the cluster labels of unlabeled data points selected from a high-density region, and then to conduct semi-supervised learning to train the model by using the estimated cluster labels and the remaining unlabeled data points. Lastly, by using the trained model, we obtain the estimated cluster labels of all given unlabeled data points. The advantage of our method is that it does not require key conditions. Existing clustering methods with deep neural networks assume that the cluster balance of a given dataset is uniform. Moreover, it also can be applied to various data domains as long as the data is expressed by a feature vector. In addition, it is observed that our method is robust against outliers. Therefore, the proposed method is expected to perform, on average, better than previous methods. We conducted numerical experiments on five commonly used datasets to confirm the effectiveness of the proposed method